We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRMY icon
1201
Harmony Biosciences
HRMY
$2.08B
$7K ﹤0.01%
189
OGS icon
1202
ONE Gas
OGS
$5.06B
$7K ﹤0.01%
86
-9
-9% -$723
RXRX icon
1203
Recursion Pharmaceuticals
RXRX
$1.61B
$7K ﹤0.01%
1,712
-9,995
-85% -$49.5K
SRPT icon
1204
Sarepta Therapeutics
SRPT
$1.63B
$7K ﹤0.01%
315
TWST icon
1205
Twist Bioscience
TWST
$5.5B
$7K ﹤0.01%
210
MAZE
1206
Maze Therapeutics
MAZE
$1.53B
$7K ﹤0.01%
+160
New +$5.5K
AGIO icon
1207
Agios Pharmaceuticals
AGIO
$2.12B
$6K ﹤0.01%
204
ANIP icon
1208
ANI Pharmaceuticals
ANIP
$1.82B
$6K ﹤0.01%
70
DVAX
1209
DELISTED
Dynavax Technologies
DVAX
$6K ﹤0.01%
409
FTRE icon
1210
Fortrea Holdings
FTRE
$1.87B
$6K ﹤0.01%
328
IBRX icon
1211
ImmunityBio
IBRX
$7.33B
$6K ﹤0.01%
3,173
KNSA icon
1212
Kiniksa Pharmaceuticals
KNSA
$6.11B
$6K ﹤0.01%
139
LEGN icon
1213
Legend Biotech
LEGN
$3.72B
$6K ﹤0.01%
254
MNKD icon
1214
MannKind Corp
MNKD
$1.21B
$6K ﹤0.01%
1,058
NRIX icon
1215
Nurix Therapeutics
NRIX
$2.5B
$6K ﹤0.01%
338
+93
+38% +$1.34K
OLMA icon
1216
Olema Pharmaceuticals
OLMA
$1.01B
$6K ﹤0.01%
224
PHVS icon
1217
Pharvaris
PHVS
$2.35B
$6K ﹤0.01%
+213
New +$5.13K
STOK icon
1218
Stoke Therapeutics
STOK
$1.84B
$6K ﹤0.01%
175
TXG icon
1219
10x Genomics
TXG
$6.04B
$6K ﹤0.01%
370
VCEL icon
1220
Vericel Corp
VCEL
$2.4B
$6K ﹤0.01%
163
ZBIO
1221
Zenas BioPharma
ZBIO
$2.04B
$6K ﹤0.01%
+179
New +$5.89K
SION
1222
Sionna Therapeutics
SION
$2.09B
$6K ﹤0.01%
+149
New +$5.65K
ALVO icon
1223
Alvotech
ALVO
$1.07B
$5K ﹤0.01%
1,030
BCRX icon
1224
BioCryst Pharmaceuticals
BCRX
$2.47B
$5K ﹤0.01%
692
EYPT icon
1225
EyePoint Inc
EYPT
$1.01B
$5K ﹤0.01%
276
+132
+92% +$1.87K

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.